APR 08, 2015 2:33 PM PDT

Allergy Drug Inhibits Hepatitis C in Mice: NIH

WRITTEN BY: Will Hector
An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.

The hepatitis C virus (HCV) causes liver inflammation and often leads to serious complications such as cirrhosis. Early diagnosis and treatment of HCV can prevent liver damage. Drugs are available to treat HCV, but costs can reach tens of thousands of dollars.

"Although hepatitis C is curable, there is an unmet need for effective and affordable medication," said lead author T. Jake Liang, M.D., senior investigator at NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "CCZ is a promising candidate for part of a treatment regimen for this potentially life-threatening disease."

Conducted at the NIH campus in Bethesda, Maryland, the study found that CCZ blocked the early stage of HCV infection likely by impairing the ability of the virus to enter human liver cells grafted in the mice. The outcome was similar to that of commonly used antiviral drugs but without those drugs' toxic side effects.

"Using an innovative high-throughput screening process, we identified CCZ as a potent inhibitor of hepatitis C," said Anton Simeonov, Ph.D., acting scientific director of NIH's National Center for Advancing Translational Sciences (NCATS), which collaborated in the study. "Identifying already approved drugs from the NCATS Pharmaceutical Collection may offer a faster route to potential discovery of treatments for all diseases."

The researchers will next study how the drug affects people. CCZ is currently used for the treatment of allergies, not for HCV. "People should not take CCZ to treat their hepatitis C until it has been demonstrated that CCZ can be used safely and effectively for that purpose," cautions Liang.

"NIH research is vital to finding creative solutions for some of today's most serious public health issues," said NIDDK Director Griffin P. Rodgers, M.D. "The CCZ medication may eventually provide an affordable alternative to costly options, especially in low-resource communities where hepatitis C infection is widespread."

(Source: NIH/National Institute of Diabetes and Digestive and Kidney Diseases)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
JAN 28, 2020
Microbiology
JAN 28, 2020
The Developing Fetus is Exposed to Bacteria in the Womb
Our bodies host many microbes, and scientists have been learning more about the role of this microbiome in our health, and when it is established....
JAN 28, 2020
Drug Discovery & Development
JAN 28, 2020
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
JAN 28, 2020
Cell & Molecular Biology
JAN 28, 2020
Stem Cell Derived Natural Killer T Cells as Novel and Long-term Cancer Treatment
Hematopoietic stem cells are used to create a population of Natural Killer T-cells that could sustain and renew within the immune system, and attack cancer cells....
JAN 28, 2020
Infographics
JAN 28, 2020
Do You Know Your Measles Immune Status?
Measles outbreaks continue to make news around the world. The Centers for Disease Control and Prevention update on a weekly basis the number of measles cas...
JAN 28, 2020
Health & Medicine
JAN 28, 2020
Could your bedding make you sick?
Do you use duvets or pillows filled with goose or duck feathers? While indeed cozy, doctors have issued a new warning related to feather filled bedding cal...
JAN 28, 2020
Cell & Molecular Biology
JAN 28, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
Loading Comments...